NewGenIvf Group Limited (NASDAQ:NIVF) Sees Significant Decline in Short Interest

Posted by Stanley Muller on Jun 29th, 2026

NewGenIvf Group Limited (NASDAQ:NIVF – Get Free Report) was the recipient of a large decrease in short interest in the month of June. As of June 15th, there was short interest totaling 89,521 shares, a decrease of 54.0% from the May 31st total of 194,483 shares. Currently, 1.3% of the company’s stock are short sold. Based on an average daily volume of 2,421,281 shares, the short-interest ratio is presently 0.0 days.

NewGenIvf Group Price Performance

NASDAQ NIVF opened at $0.56 on Monday. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. NewGenIvf Group has a 12-month low of $0.47 and a 12-month high of $372.00. The firm’s 50 day moving average is $1.11 and its 200-day moving average is $3.80.

NewGenIvf Group (NASDAQ:NIVF – Get Free Report) last announced its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) EPS for the quarter. The firm had revenue of $1.42 million for the quarter. Equities research analysts predict that NewGenIvf Group will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, April 27th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, NewGenIvf Group currently has a consensus rating of “Sell”.

Read Our Latest Research Report on NIVF

Insiders Place Their Bets

In other news, major shareholder Financial Lp Hrt bought 137,541 shares of the stock in a transaction on Friday, May 22nd. The stock was purchased at an average price of $0.99 per share, for a total transaction of $136,165.59. Following the acquisition, the insider owned 111,885 shares in the company, valued at approximately $110,766.15. This trade represents a -536.10% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 31.80% of the company’s stock.

About NewGenIvf Group

(Get Free Report)

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.